30% of Alzheimer's trials misdiagnosed
Approximately 30% of patients enrolled in Alzheimer's drug trials did not actually have Alzheimer's by pathology, having been misdiagnosed clinically.
Snapshot · The Peter Attia Drive
#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.
Explore episode
Jul 13, 2026
Where this was said
How biomarkers changed Gayatri's perspective
At 1:48:17 · chapter starts 1:47:15
This short but emotionally resonant segment captures the intellectual journey at the heart of the episode. Gayatri Devi trained in an era when Alzheimer's was considered inexorably progressive — every patient declined, no exceptions. When she began seeing patients improve with treatment, her default assumption was misdiagnosis. It was only after spinal tap biomarkers became available in 2007, allowing antemortem confirmation of amyloid and tau pathology, that she had to confront a more unsettling possibility: these patients really did have Alzheimer's and they really were getting better [1] — Gayatri Devi "The next decade in Alzheimer's care will likely be defined by AI monitoring of subtle changes in cognitive patterns for early detection, ta…" 1:49:50 . Even then, it took her another five to eight years to truly internalize that belief. Now, after 32 years in the field, she holds it with conviction — a shift she describes as one of the most significant of her career.
Biomarkers Changed What She Believes Is Possible
For decades, Gayatri Devi assumed any Alzheimer's patient who improved had been misdiagnosed. Only when spinal tap biomarkers confirmed true Alzheimer's pathology in patients who then got better did she allow herself to believe improvement was real. It took five to eight more years before she truly believed it — and now she does.
Similar snapshots
More than 3 in 4 Americans report anxiety or depression
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
Medicaid 5-year look-back rule
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
Pipe broke → hydrogen sulfide studio air
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Robot surgery: 10x less blood loss
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
115M US adults have prediabetes
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths: 110K to 80K to 70K
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose rate fell 27% in one year
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
Ages 15–24 overdose deaths down 37%
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Nurses walk miles per shift fetching items
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
